Week in review: Neffy repeat dose study data, fostering healthy eating habits

News
Article

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Image credit: Contemporary Pediatrics

Image credit: Contemporary Pediatrics

Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from last week (Monday, February 19 to Friday, February 23, 2024), and click on each link to read and watch anything you may have missed.

1.) Neffy epinephrine nasal spray demonstrates positive data in repeat dosing study

ARS Pharma plans to submit data from the repeat dose study of neffy to the FDA early in the second quarter of 2024, as part of its response to the CRL issued by the federal agency for the previously submitted New Drug Application (NDA).

Click here for the full article.

2.) Fostering healthy eating habits

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her perspectives on the most recent issue of Contemporary Pediatrics.

Click here for her full commentary and highlights.

3.) Identifying arrhythmias in children using smartwatch technology

How effective can wearable technology with features designed for adults be for children when it comes to arrhythmias? Scott Ceresnak, MD, helps provide the answer in this Contemporary Pediatrics interview.

Click here to watch the full video interview.

4.) FDA grants Priority Review to pitolisant for pediatric narcolepsy patients

A Prescription Drug User Fee Act (PDUFA) target action date has been set for June 21, 2024, following a supplemental New Drug Application (sNDA) submission by Harmony Biosciences.

Click here for full details.

5.) Duchenne muscular dystrophy treatment receives Rare Pediatric Disease designation

The FDA has granted a Rare Pediatric Disease Designation to Avidity Biosciences' AOC 1044, an investigational therapy to treat Duchenne muscular dystrophy (DMD) in patients with mutations amenable to exon 44 skipping (DMD44).

Fast Track Designation and Orphan Designation was previously granted to AOC 1044.

Click here for full details.

Related Videos
Angela Nash, PhD, APRN, CPNP-PC, PMHS | Image credit: UTHealth Houston
Allison Scott, DNP, CPNP-PC, IBCLC
Joanne M. Howard, MSN, MA, RN, CPNP-PC, PMHS & Anne Craig, MSN, RN, CPNP-PC
Juanita Mora, MD
Natasha Hoyte, MPH, CPNP-PC
Lauren Flagg
Venous thromboembolism, Heparin-induced thrombocytopenia, and direct oral anticoagulants | Image credit: Contemporary Pediatrics
Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
Sally Humphrey, DNP, APRN, CPNP-PC | Image Credit: Contemporary Pediatrics
© 2024 MJH Life Sciences

All rights reserved.